BioSpace News Archive

Takeda Presents Full Data Set from Phase 3 ADVANCE-CIDP 1 Clinical Trial Investigating HYQVIA ® as a Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) at PNS Annual Meeting.

ContraFect Corporation announces the presentation of data showing significant activity of its direct lytic agents against the most drug-resistant Gram-negative pathogens, including Pseudomonas aeruginosa, Klebsiella pneumoniae and Burkholderia spp, at ASM Microbe 2023 held from June 15-19, 2023 in Houston, Texas.

Longbio Pharma announced the preliminary phase I data of LP-003 (new generation of anti-IgE antibody) at the 29th Congress of European Rhinologic Society (ERS2023).

Sengenics Corporation LLC announces that it has entered into a sales and marketing agreement with French distributor Proteigene to make Sengenics’ suite of services and products more widely available in France.

BrainStorm Cell Therapeutics Inc. today announced the appointment of Nir Naor, CPA, CFA, MBA (IMD), LL.M, as Board Member, chairman of its Audit Committee and member of its Governance, Nomination and Compensation Committee.

Zynex, Inc today announced that the FDA (Food and Drug Administration) has granted 510(k) market clearance for the company’s CM-1600 blood and fluid volume monitoring device.

ClearB Therapeutics, Inc. announced today that two abstracts were accepted for poster presentation at the European Association for the Study of the Liver (EASL) International Liver Congress (ILC) 2023, taking place in Vienna, Austria June 21 - 24, 2023.

BostonGene Highlights Approach to IO Research and Precision Medicine at the 6th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference.

G42 Healthcare’s Somalogic Proteomics Laboratory, part of the Omics Centre of Excellence, is now officially certified with the SomaScan Discovery Assay, making it the first certified Proteomics site in EMEA region.

Today, the U.S. Food and Drug Administration announced a new voluntary pilot program for certain oncology drug products used with certain corresponding in vitro diagnostic tests to help clinicians select appropriate cancer treatments for patients.